The customer questioned high results for 1 patient tested for elecsys ca 19-9 immunoassay (ca 19-9).The customer thinks there may be an interferent in the sample and sent the sample in for investigation.During the investigation, erroneous results were identified between the customer¿s cobas 8000 core unit, an e 602 analyzer used at the investigation site and the lumipulse method.It is not known if the customer reported the high result outside of the laboratory.The results from the investigation will be provided to the customer.In (b)(6) 2016, the patient¿s ca 19-9 result was 40 u/ml.On (b)(6) 2016 the patient had a result of 4631 u/ml.Since this result was suddenly elevated, the customer suspected an interference and requested an investigation of the sample.Refer to the attached data for the results obtained during the investigation.A neuraminidase test on the sample was also performed.Refer to the attached data for the results from the sample before it was treated with neuraminidase and after it was treated with neuraminidase.No adverse event occurred.The customer¿s 8000 core unit serial number was (b)(4).The e602 analyzer serial number used at the investigation site was (b)(4).The ca 19-9 reagent lot number used at the investigation site was 188632 with and expiration date of 05/2017.The ca 19-9 results were different between the different manufacturers, however, both assays indicate the ca 19-9 results are high.The discrepancy may be due to the different set up of each assay and the different antibodies affecting test results.
|
An interference was not identified during the investigation.Based upon the information provided for investigation, the ca 19-9 results are believed to be correct.Although the results were different between the two manufacturers, both assays indicate high ca 19-9 results.
|